secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eledon Pharmaceuticals, Inc. (ELDN)
CIK:        0001404281
Form:       8-K
Filed at:   2024-07-12T23:59:59+00:00
Accession:  0000950170-24-083220
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eledon Pharmaceuticals replaces auditor KMJ Corbin with Crowe LLP; no disagreements reported
--------------------------------------------------------------------------------

- Audit committee dismissed KMJ Corbin and appointed Crowe LLP on July 10, 2024, after KMJ partners joined Crowe.
- KMJ's reports for fiscal years 2022 and 2023 contained no adverse opinion but included a going concern explanatory paragraph.
- No disagreements or reportable events occurred during the two most recent fiscal years and subsequent interim period.
- KMJ provided a letter agreeing with the company's statements, filed as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404281/000095017024083220/0000950170-24-083220-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404281/000095017024083220/eldn-20240710.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-083220

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer